Literature DB >> 2208108

Role of carrier ligand in platinum resistance in L1210 cells.

G R Gibbons1, J D Page, S K Mauldin, I Husain, S G Chaney.   

Abstract

We have examined the effect of carrier ligands on platinum accumulation, incorporation of platinum into DNA, cytotoxicity of Pt-DNA adducts, and repair of Pt-DNA adducts in three L1210 cell lines: L1210/0, which is sensitive to most types of platinum compounds; L1210/DDP, which is resistant to platinum compounds with the ethylenediamine (en) carrier ligand but sensitive to those with the diaminocyclohexane (dach) ligand; and L1210/DACH, which is resistant to dach-Pt compounds but sensitive to en-Pt compounds. There was a selective decrease in accumulation of dach-Pt in the L1210/DACH line and of en-Pt in the L1210/DDP line. Intracellular dach-Pt was incorporated into DNA to a lesser extent than en-Pt in both resistant cell lines. Cytotoxicity of en-Pt adducts was less than that of dach-Pt adducts in the L1210/DDP line, while the reverse was true in the L1210/DACH line. Increased repair was seen in both resistant cell lines; a carrier ligand effect was seen only in the L1210/DDP line, which showed a greater initial rate of repair for en-Pt than dach-Pt adducts. These data suggest that carrier ligand effects seen in resistant cell lines may be due, in part, to differences in accumulation of platinum, repair of Pt-DNA adducts, and tolerance of Pt-DNA adducts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208108

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.

Authors:  Orren Beaty; Stacey Berg; Susan Blaney; Marcio Malogolowkin; Mark Krailo; Ronald Knight; Paula Schaiquevich; Clinton Stewart; Zhengjia Chen; Marvin Nelson; Stephan Voss; S Percy Ivy; Peter C Adamson
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

2.  Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.

Authors:  P Calsou; P Frit; B Salles
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

3.  An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts.

Authors:  D E Szymkowski; K Yarema; J M Essigmann; S J Lippard; R D Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells.

Authors:  J A Vilpo; L M Vilpo; D E Szymkowski; A O'Donovan; R D Wood
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

5.  Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance.

Authors:  Rn Seetharam; A Sood; S Goel
Journal:  Ecancermedicalscience       Date:  2009-09-24

6.  Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).

Authors:  D Rischin; V Ling
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

7.  Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.

Authors:  S Kishimoto; K Miyazawa; Y Terakawa; H Ashikari; A Ohtani; S Fukushima; Y Takeuchi
Journal:  Jpn J Cancer Res       Date:  2000-12

Review 8.  Modulation of cis-diamminedichloroplatinum(II) resistance: a review.

Authors:  H Timmer-Bosscha; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

9.  Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer.

Authors:  Sisi Wang; Hongyong Zhang; Tiffany M Scharadin; Maike Zimmermann; Bin Hu; Amy Wang Pan; Ruth Vinall; Tzu-yin Lin; George Cimino; Patrick Chain; Momchilo Vuyisich; Cheryl Gleasner; Kim Mcmurry; Michael Malfatti; Kenneth Turteltaub; Ralph de Vere White; Chong-xian Pan; Paul T Henderson
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

10.  The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).

Authors:  T Ohmori; T Morikage; Y Sugimoto; Y Fujiwara; K Kasahara; K Nishio; S Ohta; Y Sasaki; T Takahashi; N Saijo
Journal:  Jpn J Cancer Res       Date:  1993-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.